🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Has anyone dealt with surmount-2: tirzepatide for t2dm + obesity? Page 2

Has anyone dealt with surmount-2: tirzepatide for t2dm + obesity?

claudia_zurich Fri, Jan 31, 2025 at 8:00 PM 37 replies 1,853 viewsPage 2 of 8
SkepticalSean
Member
98
345
Jan 2025
Maine
Jan 31, 2025 at 10:50 PM#6

The early improvement Michelle describes is consistent with the hypothesis that some of tirz's OSA benefit is weight-independent. Fat deposition in the parapharyngeal space (around the throat) may redistribute or reduce earlier than total body weight change would predict, possibly due to GIP-mediated effects on visceral/ectopic fat deposits.

There's also emerging data on GLP-1 receptor expression in the brainstem respiratory centers (nucleus tractus solitarius) that could influence respiratory drive during sleep. This is very preliminary but mechanistically plausible.

23 10DerekSJ_a1c, paige_pharma, emma_london and 20 others
Reply Quote Save Share Report
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
Jan 31, 2025 at 11:07 PM#7

Thank you all. I'm on 7.5mg currently, 3 months in, down 28 lbs. My wife says the snoring is "significantly better" but not gone. I've got a repeat sleep study scheduled for month 6. Fingers crossed my numbers look like Michelle's. 🤞

Dr. Martinez — thank you for the responsible reminder about not stopping CPAP without proper testing. As much as I hate the machine, I'll wait for data before making any changes.

12 years of CPAP, maybe not 13

40 14Dr.PathRoch, mona_PHX, andrew_nyc and 37 others
Reply Quote Save Share Report
marcus_mpls
Member
234
1,123
Nov 2024
Minneapolis, MN
Jan 31, 2025 at 11:24 PM#8

Brian — 28 lbs in 3 months with subjective snoring improvement is very encouraging. I'd expect your AHI to have improved meaningfully already. The month 6 study will give you the data you need.

And yes — patience with the CPAP. I know it's annoying but unmonitored discontinuation can be dangerous, especially if there's residual moderate-severe OSA. The repeat study will tell you if it's safe to stop.

I'm genuinely excited about where this field is going. The combination of effective weight loss medications and improved PAP technology means we have more tools than ever for OSA management. Good times for our patients. 👍

22 4tane_welly, Dr.PathRoch, mona_PHX and 19 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register